21. The Gavi Mid-Term Review: Progress to Date and Prospects for 2021 and Beyond
- Author:
- Katherine E. Bliss
- Publication Date:
- 01-2019
- Content Type:
- Working Paper
- Institution:
- Center for Strategic and International Studies
- Abstract:
- Gavi, The Vaccine Alliance, is making good progress toward meeting its current targets and is adapting its programs to continue delivering lifesaving products to the world’s poorest populations in the face of significant external pressures and challenges. However, as Gavi looks ahead to its next strategic phase and considers how conflicts and humanitarian crises, climate change, urbanization, and population growth will affect its work, it will need to evolve its partnership model and market-shaping approaches to ensure that the large numbers of poor children, including, potentially, many who live in non-eligible countries, are fully immunized. The Alliance highlighted its accomplishments and challenges faced thus far during the 2016-2020 work phase at a mid-term review held December 2018 in Abu Dhabi. The more than 300 participants included heads of state and ministers of health, as well as representatives of vaccine manufacturers, private sector organizations, donor governments, and implementing agencies. Over plenaries, panels, and breakaway sessions the diverse mix of Gavi partners considered ways to make the Alliance more effective in a changing geopolitical environment as it gears up for its next replenishment, to be held in 2020.
- Topic:
- Public Health, Vaccine, Medicine, and Immunization
- Political Geography:
- Global Focus